Laropiprant Uses, Dosage, Side Effects and more
Laropiprant is an ingredient in the EMA-withdrawn product Pelzont.
| Trade Name | Laropiprant |
| Generic | Laropiprant |
| Laropiprant Other Names | Laropiprant |
| Type | |
| Formula | C21H19ClFNO4S |
| Weight | Average: 435.89 Monoisotopic: 435.0707351 |
| Groups | Approved, Investigational, Withdrawn |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
